July 11, 2018

TFF Pharmaceuticals Receives Notice of Allowance for New Foundational Patent Broadly Covering Novel Inhaled Dry Powder Drug Delivery Platform

May 8, 2018

TFF Pharmaceuticals Announces Appointment of Glenn Mattes as New Chief Executive Officer

May 3, 2018

Biopharm Startup TFF Pharmaceuticals Raises $14M for Breakthrough Dry Powder Inhalation Platform